Skip to main content

Table 3 Risk factors of CMV disease

From: Cytomegalovirus seroprevalence, infection, and disease in Chinese thoracic organ transplant recipients: a retrospective cohort study

Variables

Univariate analysis

Multivariate analysis

OR (95% CI)

P value

OR (95% CI)

P value

Age

1.02 (1.00–1.05)

0.06

Sex (male vs. female)

1.80 (0.68–4.80)

0.24

Body mass index

1.57 (0.72–1.84)

0.57

Basiliximab (yes vs. no)

0.27 (0.06–1.15)

0.08

r–ATG (> 2 vs. ≤ 2 mg/kg)

3.39 (1.64–6.99)

0.001

4.25 (1.92–9.42)

0.001

Serostatus (D+/R vs. other)

13.82 (1.52–125.65)

0.02

18.32 (1.80–188.68)

0.014

No valganciclovir (true vs. false)

3.35 (1.45–7.74)

0.005

2.64 (1.05–6.64)

0.039

  1. Heart-lung transplantation is included in double-lung transplantation. CMV cytomegalovirus, D+ CMV seropositive donors, R CMV seronegative recipients, r-ATG rabbit anti-human thymocyte globulin, OR odds ratio, CI confidence interval